FindTrial
Sign In

Effects of Remimazolam vs. Propofol on Early Postoperative Cognitive Recovery in Day-Case Endoscopic Ear Surgery: A Randomized Controlled Trial

Effects of Remimazolam vs. Propofol on Early Postoperative Cognitive Recovery in Day-Case Endoscopic Ear Surgery: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500109239
Enrollment
Unknown
Registered
2025-09-16
Start date
2025-09-22
Completion date
Unknown
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Postoperative Cognitive Recovery

Interventions

propofol:propofol +remifentanil
remimazolam:remimazolam++remifentanil

Sponsors

Shanghai Eye & ENT hosoital , Fudan university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients (18–65 years old) having American Society of Anesthesiologists (ASA) physical status of I-II undergoing middle ear endoscopic surgery under general anesthesia were enrolled .

Exclusion criteria

Exclusion criteria: Patients with a history of hypersensitivity to study medications or to dextran 40, moderate hepatic dysfunction, metabolic disease, and acute glaucoma were excluded.

Design outcomes

Primary

MeasureTime frame
DSST recovery one hour after extubation.;recovery profile(time to extubation,time to gain spatial orientation);—

Secondary

MeasureTime frame
demographic profiles(including education level);field visibility;hearing function;hemodynamic profiles;BIS;consumption of anesthetics;—

Countries

China

Contacts

Public ContactShen Xia

Shanghai Eye & ENT hospital, Fudan University

shenxiash@fudan.edu.cn+86 136 1187 4118

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026